Fundai

Reavard Tamin Pharmaceutical Company (DAREAVAR) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DAREAVAR
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations4,197,429-145,421603,7381,343,127800,331152,235
Cash payments for income tax-955,282-56,003-217,716-138,676-63,898-25,860
Net cash inflow (outflow) from operating activities3,242,147-201,424386,0221,204,451736,433126,375
Cash payments for purchase of property, plant and equipment-737,375-450,540-304,128-146,696-69,059-32,462
Cash receipts from interest on other investments4821,348359,401135,47812,7522,548
Net cash inflow (outflow) from investing activities-736,893-469,8611,270,159-310,218174,064-34,103
Net cash inflow (outflow) before financing activities2,505,254-671,2851,656,181894,233910,49792,272
Cash receipts from sale of treasury shares574,94667,34896,511111,36653,4370
Cash payments for purchase of treasury shares-641,433-82,609-137,822-133,667-30,472-21,154
Cash receipts from facilities4,523,7303,605,0633,126,7503,144,7952,243,9381,824,191
Cash payments for principal of loans-4,181,169-2,487,792-2,986,833-3,032,006-2,142,460-1,703,200
Cash payments for interest on loans-679,930-153,743-279,730-223,503-144,384-144,018
Cash payments for dividends-543,457-699,496-1,565,650-14,235-55,729-95,354
Net cash inflow (outflow) from financing activities-947,313248,771-1,746,774-147,250-75,670-139,535
Net increase (decrease) in cash1,557,941-422,514-90,593746,983834,827-47,263
Cash balance at beginning of year1,749,7681,453,6421,745,966561,046225,282164,766
Effect of changes in exchange rates57,3588352,58200-48
Cash balance at end of year3,365,0671,031,9631,657,9551,308,0291,060,109117,455

Reporting periods

31 periods are on file for this report, from the period ending 1396/12/29 to the period ending 1405/06/31.